Sirolimus trials
| | | | | | | | | | | | | |
SIRIUS (2003)4 | Stable or unstable AP, signs of myocardial ischaemia | 2.80 | 14.40 | 44 | 31 | 25 | 8 | 36 | 33 | 23 | 42 | 31 | 58 | 53 |
E-SIRIUS (2003)1 | Stable or unstable AP, silent ischaemia | 2.55 | 15.00 | 56 | 21 | 23 | NA | NA | NA | NA | 36 | 42 | NA | 33 |
C-SIRIUS (2004)3 | Stable or unstable AP, silent ischaemia | 2.63 | 13.60 | 36 | 41 | 23 | NA | NA | 59 | | 40 | 42 | 12 | 51 |
DIABETES (2005)30 | Symptoms or objective evidence of ischaemia | 2.34 | 15.00 | 41 | 37 | 22 | NA | NA | 80 | | 65 | 37 | NA | NA |
RAVEL (2002)2 | Stable or unstable AP, silent ischaemia | 2.62 | 9.58 | 50 | 27 | 23 | 6 | 37 | 57 | 0 | NA | 36 | 39 | 50 |
SES-SMART (2004)8 | ACS, stable AP, silent myocardial ischaemia as shown by exercise stress test | 2.20 | 11.84 | 28 | 16 | 30 | 25 | 47 | 24 | 4 | 65 | NA | NA | NA |
Paclitaxel trials
| | | | | | | | | | | | | |
TAXUS I (2003)5 | Stable or unstable AP or silent ischaemia | 2.97 | 11.30 | 40 | 30 | 30 | 23 | 41 | 36 | 0 | NA | 28 | NA | NA |
TAXUS II (2003)6, 32, 33 | Stable or unstable AP or silent ischaemia | 2.75 | 10.48 | 45 | 36 | 19 | NA | NA | NA | NA | NA | 40 | 60 | 34 |
TAXUS IV (2004)7, 29 | Stable or unstable angina or provokable ischaemia | 2.75 | 13.40 | 41 | 31 | 28 | NA | NA | NA | NA | NA | 30 | NA | 34 |
TAXUS VI (2005)31 | Stable or unstable AP or silent ischaemia | 2.78 | 20.62 | | | | NA | NA | 28 | 56 | NA | NA | NA | NA |